Document is current
Any future updates will be listed below
-
Authors
Ozair, Ahmad
Collings, Amelia
Adams, Alexandra M.
Dirks, Rebecca
Kushner, Bradley S.
Sucandy, Iswanto
Morrell, David
Abou-Setta, Ahmed M.
Vreeland, Timothy
Whiteside, Jake
Cloyd, Jordan M.
Ansari, Mohammed T.
Cleary, Sean P.
Ceppa, Eugene
Richardson, William
Alseidi, Adnan
Awad, Ziad
Ayloo, Subhashini
Buell, Joseph F.
Orthopoulos, Georgios
Sbayi, Samer
Wakabayashi, Go
Slater, Bethany J.
Pryor, Aurora
Jeyarajah, D. Rohan http://orcid.org/0000-0002-1673-678X
- License Information
-
More Information
Article History
Received: 19 May 2022
Accepted: 5 September 2022
First Online: 22 September 2022
Declarations
:
: Amelia Collings is employed by SAGES as the guideline’s fellow. Alexandra M. Adams receives financial support for travel expenses and registration fees for annual meetings for SAGES and AHPBA from the Metis Foundation. Rebecca Dirks has privately purchased stock in Johnson & Johnson. Ahmed M. Abou-Setta and Mohammed T. Ansari are consultant methodologists and remunerated by SAGES for contribution to this work. Timothy Vreeland receives financial support for travel expenses and registration fees for meetings from the Metis Foundation and consulting fees from Bantam Pharmaceuticals for clinical trial design. Sean P. Cleary receives consulting fees from Ethicon, Erbe, and Olympus. Joseph F. Buell receives speaker and consulting fees from Ethicon and Covidien. Bethany J. Slater receives consulting fees from Bolder Surgical and Cook Medical. Aurora Pryor receives speaker fees from Gore, Ethicon, and Stryker. Ahmad Ozair, Bradley S. Kushner, Iswanto Sucandy, David Morrell, Jake Whiteside, Jordan M. Cloyd, Eugene Ceppa, William Richardson, Adnan Alseidi, Ziad Awad, Subhashini Ayloo, Georgios Orthopoulos, Samer Sbayi, Go Wakabayashi, D. Rohan Jeyarajah have no conflicts of interest.
